29 th June 2022, New Delhi: India’s Leading ln-vitro Diagnostic Company, Transasia Bio-Medicals Ltd. has been recognized as among the Best Healthcare Brands in India in 2022. This recognition has been bestowed upon by The Economic Times – the world’s second-most widely read English- language business newspaper.
On receiving the award, Mr. Suresh Vazirani, Founder and Chairman, Transasia-Erba Group said, “It is an honor for India’s Leading IVD Company to cement its position among the best Indian healthcare companies. I would like to thank the clinical laboratory community for their unfading trust in us. We will continue to equip India with indigenously manufactured, sophisticated technologies that are adoptable, accessible, and affordable. Most importantly, we continue to take great strides in our commitment towards a Healthier and Happier World.”
Mr. Vinay Sareen, Vice President, Sales and Marketing, Transasia Bio-Medicals received the award. On behalf of Transasia through the hands of Dr. Montu Kumar Patel. Dr. Montu Kumar Patel, President, Pharmacy Council of India. The event was also attended by Shri Vishal Chauhan, Joint Secretary, MoH& FW, GoI.
This is the third time that Transasia has been recognized among the Best Healthcare Brands by The Economic Times.
